Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AtCor Medical, a developer of cardiovascular technologies for risk assessment and patient management, has signed a new contract to supply SphygmoCor systems and clinical trial support services to an international pharmaceutical company.
Subscribe to our email newsletter
This contract is with an existing client, and has a minimum value of $579,000. The contract brings the total value of US pharmaceutical trial contracts secured over the past 11 months to $7.9 million, said AtCor.
Duncan Ross, CEO of AtCor Medical, said: “We are again very pleased to announce additional business from an existing client. AtCor’s strong customer retention in new clinical trials demonstrates the importance of noninvasive central blood pressure data in drug development, as well as the high quality of the services we provide.”